Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of LY03015 in Healthy Chinese and Caucasian Adults
NCT07671833Phase 1Completed
- Sponsor
- Luye Pharma Group
- Start
- Apr 2026
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of LPM3770164 (2 arms), sponsored by Luye Pharma Group. Primary endpoint: Pharmacokinetic profile of LY03015 at 15 days. Started Apr 2026; status: completed.
02
Drugs
LPM3770164
Beyond the preview
Go deeper on NCT07671833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07671833.